Bicocca Open Archive

Logo unimib boa
POGLIANI, ENRICO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.151
AS - Asia 5.868
EU - Europa 4.812
SA - Sud America 969
AF - Africa 157
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 11
Totale 23.984
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.688
SG - Singapore 2.128
CN - Cina 1.377
HK - Hong Kong 943
DE - Germania 808
RU - Federazione Russa 748
BR - Brasile 725
SE - Svezia 638
IE - Irlanda 614
VN - Vietnam 577
UA - Ucraina 558
IT - Italia 540
CA - Canada 388
GB - Regno Unito 261
FR - Francia 202
IN - India 196
FI - Finlandia 140
KR - Corea 115
BD - Bangladesh 94
AR - Argentina 81
IQ - Iraq 63
JP - Giappone 58
TR - Turchia 58
NL - Olanda 55
ZA - Sudafrica 54
EC - Ecuador 50
AT - Austria 42
PK - Pakistan 42
ES - Italia 41
MX - Messico 41
PL - Polonia 35
DK - Danimarca 34
ID - Indonesia 31
SA - Arabia Saudita 31
CO - Colombia 30
BE - Belgio 28
PH - Filippine 25
VE - Venezuela 23
MA - Marocco 19
UZ - Uzbekistan 19
CL - Cile 18
EG - Egitto 18
PY - Paraguay 17
ET - Etiopia 14
EU - Europa 14
TN - Tunisia 14
KE - Kenya 13
LT - Lituania 12
MY - Malesia 11
UY - Uruguay 11
AE - Emirati Arabi Uniti 10
DO - Repubblica Dominicana 10
BG - Bulgaria 9
NP - Nepal 9
AU - Australia 8
OM - Oman 8
PE - Perù 8
RO - Romania 8
AZ - Azerbaigian 7
DZ - Algeria 7
PS - Palestinian Territory 7
TH - Thailandia 7
JO - Giordania 6
KZ - Kazakistan 6
CZ - Repubblica Ceca 5
IL - Israele 5
LB - Libano 5
AL - Albania 4
BH - Bahrain 4
HU - Ungheria 4
IR - Iran 4
JM - Giamaica 4
PA - Panama 4
PT - Portogallo 4
RS - Serbia 4
TW - Taiwan 4
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
HR - Croazia 3
KH - Cambogia 3
LK - Sri Lanka 3
MK - Macedonia 3
NI - Nicaragua 3
SN - Senegal 3
AM - Armenia 2
BW - Botswana 2
CH - Svizzera 2
CI - Costa d'Avorio 2
GA - Gabon 2
HN - Honduras 2
KG - Kirghizistan 2
KW - Kuwait 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SR - Suriname 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
Totale 23.960
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.839
Ashburn 1.148
Singapore 1.124
Woodbridge 1.038
Hong Kong 925
Houston 750
Fairfield 647
San Jose 612
Dublin 600
Jacksonville 590
Chandler 457
Frankfurt am Main 400
Wilmington 373
Dearborn 323
New York 299
Seattle 258
Princeton 224
Beijing 210
Cambridge 207
Toronto 202
Chicago 182
Los Angeles 181
Ho Chi Minh City 173
Milan 163
Hefei 142
Hanoi 141
Santa Clara 140
The Dalles 133
Nanjing 129
Shanghai 125
Seoul 108
Lawrence 103
Lachine 102
Altamura 100
Lauterbourg 98
Dallas 91
Moscow 77
Buffalo 76
São Paulo 69
Göttingen 52
Council Bluffs 45
Guangzhou 44
Nanchang 42
Changsha 40
Tokyo 39
Andover 37
San Diego 35
Vienna 33
London 32
Shenyang 32
Orem 31
Ottawa 29
Boardman 28
Brussels 28
Hebei 28
Munich 27
Warsaw 27
Rio de Janeiro 26
Helsinki 25
Haiphong 24
Johannesburg 24
Atlanta 23
Montreal 23
Baghdad 22
Huizen 22
Salt Lake City 19
Denver 18
Fürstenwalde 18
Guayaquil 18
Jiaxing 18
Jinan 18
Tampa 18
Tianjin 18
Chennai 17
Da Nang 17
Fremont 17
Lahore 17
Manchester 17
Pune 17
Rome 17
Tashkent 17
Brooklyn 16
Dhaka 16
Hangzhou 16
Lissone 16
Norwalk 16
Redmond 16
Zhengzhou 16
Jeddah 15
New Delhi 15
Nürnberg 15
University Park 15
Mumbai 14
Boston 13
Kunming 13
Mountain View 13
Poplar 13
Addis Ababa 12
Campinas 12
Elk Grove Village 12
Totale 15.932
Salva come PNG Salva come JPEG
Nome #
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 555
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 481
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia 453
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib 443
Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia: Results At 8 Years 422
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 407
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 382
A boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation 376
Imatinib long term effects study: three years of follow-up and assessment 369
Good outcome for very high risk adult B-cell acute lymphoblastic leukaemia carrying genetic abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if promptly submitted to allogeneic transplantation, after obtaining a good molecular remission 356
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 348
Thrombosis of the splenoportal axis after splenectomy 345
A CASE OF ATYPICAL PROLONGED HEMATOLOGIC TOXICITY WITH AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), REVIEW OF LITERATURE AND A PROPOSAL OF MANAGEMENT 304
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 300
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: A phase I study 291
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients 291
Circulating endothelial cells and endothelial activation in essential thrombocythemia: Results from CD146(+) immunomagnetic enrichment-flow cytometry and soluble E-selectin detection 285
Severe, reversible nelarabine-induced neuropathy and myelopathy 281
Development of polycythemia vera after chemotherapy-induced remission of acute myeloid leukemia: a case report 279
Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis 276
CML Patients Present Additional Mutations in Cancer Related Genes When Tested At Diagnosis 271
Neurological symptoms in essential thrombocythemia: Impact of JAK2V617F mutation and response to therapy 269
A prospective study on cardiovascular events after acute pulmonary embolism 267
Combined prophylactic low-molecular weight heparin and low dose aspirin reduces the occurrences of adverse pregnancy outcome in multiparous women with preeclampsia and intrauterine fetal growth restriction in antecedent pregnancy 262
Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies 260
CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease 257
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 256
The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years 252
Recurrent preeclapsia: The role of acquired and heritable thrombophilia 251
A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study) 250
Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma 249
Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination 246
Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy 243
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 241
Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy 241
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry 239
Iron chelation therapy with deferasirox in the management of iron overload in primary myelofibrosis 233
BCR AND BCR-ABL REGULATION DURING MYELOID DIFFERENTIATION IN HEALTHY DONORS AND CHRONIC PHASE-BLAST CRISIS CML PATIENTS 231
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) 231
Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: A case report 229
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect 224
NPM/ALK binds and phosphorylates the RNA/DNA binding protein PSF in anaplastic large cell lymphoma 222
Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR) 222
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance 222
High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study 221
Autoimmune hepatitis presenting as imatinib toxicity: description of a case and of therapeutic alternatives 219
Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect? 217
Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone 216
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients 208
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: A randomized study 207
Venous thromboembolism and cancer: Guidelines of the Italian Association of Medical Oncology (AIOM) 206
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group 206
Resistance Profile of the BCR/ABL Inhibitor Bosutinib Using a High Throughput random Mutagenesis Assay 204
Atypical presentation of Upshaw-Schulman syndrome in a pregnant patient homozygous for V Leiden mutation 204
Platelet activation during plasma-reduced multicomponent PLT collection: A comparison between COBE Trima and Spectra LRS turbo cell separators 202
Imatinib failed to eradicate chronic myeloid leukemia in a patient with minimal residual disease 201
Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients 200
Frozen-and-thawed allogeneic platelet gels for treating postoperative chronic wounds 199
Crizotinib in anaplastic large-cell lymphoma 198
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial 197
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL) 194
Prevention of venous thromboembolism in immobilized neurological patients: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 194
Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies 192
Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00 185
Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation 184
Reviewed diagnosis of primary and secondary immune thrombocytopenic purpura in 79 adult patients hospitalized in 2000 - 2002 181
CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11) 180
Development of c-Kit-expressing Small-Cell lung Cancer in a Chronic Myeloid Leukemia Patient During Imatinib Treatment 177
Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia 177
SIGNIFICANT REDUCTION IN FASTING BLOOD GLUCOSE IN NONDIABETIC PH+ CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB MESYLATE 175
Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: A prospective multicentre study 173
A case of Philadelphia Positive Acute Lymphoblastic Leukaemia with three different phenotypic lineage, each one presenting the same BCR-ABL hybrid transcript 171
Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: case-control study in patients with multiple myeloma and review of the literature 171
Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trials 171
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned 170
HOMOZYGOSITY FOR JAK2V617F IDENTIFIES MPD PATIENTS WITH A MORE SYMPTOMATIC DISEASE A RETROSPECTIVE STUDY ON 989 PATIENTS FROM THE GIMEMA-MPD WORKING PARTY 170
Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenström's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: Proposal for a common prognostic scoring system 169
Cytomegalovirus infection after autologous stem cell transplantation: incidence and outcome in a group of patients undergoing a surveillance program 163
Low Efficiency of a Newly Introduced High-Density Microparticles Method for B Cell Depletion in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation 163
Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD 162
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 160
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes 159
Advanced mast cell disease: an Italian Hematological Multicenter experience 159
From Vaquez to Dameshek through JAK…2 much for polycythemia vera to be feared? 158
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage 156
Fully immunocompetent CD8+ T lymphocytes are present in autologous haematopoietic stem cell transplantation recipients despite an ineffectual T-helper response 156
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia 155
Management of poor peripheral blood stem cell mobilization: Incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions 154
Imatinib concentrations in human milk 151
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 150
Corticosteroids can reverse severe imatinib-induced hepatotoxicity 148
The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma 145
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients 145
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome 142
Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate 141
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia 140
In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' [2] 139
Molecular purging of multiple myeloma cells by ex-vivo culture and retroviral transduction of mobilized-blood CD34+ cells 139
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study 139
Mast cell leukemia: A report of ten cases 139
Totale 22.914
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.887
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.887
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021151 0 0 0 0 0 0 0 0 0 0 66 85
2021/20221.088 50 58 90 111 85 103 42 85 71 92 106 195
2022/20232.038 293 671 195 163 127 311 17 79 109 6 34 33
2023/20241.665 38 45 54 78 244 490 341 47 174 13 21 120
2024/20253.085 211 356 120 138 296 75 122 75 319 462 312 599
2025/20267.768 764 566 669 953 969 455 1.212 449 687 740 304 0
Totale 24.306